Utilizing Targeted Next-Generation Sequencing for Rapid, Accurate, and Cost-Effective Pathogen Detection in Lower Respiratory Tract Infections
Authors:
Open Access
- 1 January 2025
- journal article
- research article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 18, 329-340
Abstract
Objective: To evaluate the diagnostic performance and clinical impact of targeted next-generation sequencing (tNGS) in patients with suspected lower respiratory tract infections. Methods: Following propensity score matching, we compared the diagnostic performances of tNGS and metagenomic next-generation sequencing (mNGS). Furthermore, the diagnostic performance of tNGS was compared with that of culture, and its clinical impact was assessed. Results: After propensity score matching, the coincidence rate of tNGS was comparable to that of mNGS (82.9% vs 73.9%, P=0.079). The detection rates for bacterial, viral, fungal, and mixed infections were not significantly different (P> 0.05). Bacterial-viral co-infection (16.7%) was the most common mixed infection detected by tNGS. tNGS showed a higher detection rate than culture (75.2% vs 19.0%, P< 0.01). The positive detection rate by tNGS was not significantly different between immunocompromised and immunocompetent patients (88.6% vs 80.5%, P=0.202), but was significantly higher than that by culture (P< 0.001). Moreover, 65 patients (44.5%) had their medications modified based on the tNGS results, and the majority exhibited notable improvement regardless of treatment adjustment. Conclusion: tNGS performs comparably to mNGS and surpasses culture in detecting lower respiratory tract infections. Nevertheless, tNGS is faster and more cost-effective than mNGS, making it highly significant for guiding rational treatment.Keywords
This publication has 34 references indexed in Scilit:
- Targeted next generation sequencing is comparable with metagenomic next generation sequencing in adults with pneumonia for pathogenic microorganism detectionJournal of Infection, 2022
- Metagenomic next-generation sequencing for accurate diagnosis and management of lower respiratory tract infectionsInternational Journal of Infectious Diseases, 2022
- Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infectionsInternational Journal of Antimicrobial Agents, 2022
- Exploring the Clinical Utility of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary InfectionInfectious Diseases and Therapy, 2021
- Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patientsJournal of Infection, 2021
- Metagenomic next-generation sequencing technology for detection of pathogens in blood of critically ill patientsInternational Journal of Infectious Diseases, 2021
- Etiology of Severe Community-Acquired Pneumonia in Adults Based on Metagenomic Next-Generation Sequencing: A Prospective Multicenter StudyInfectious Diseases and Therapy, 2020
- Treatment of Community-Acquired Pneumonia in Immunocompromised AdultsChest, 2020
- Next-generation sequencing of the BALF in the diagnosis of community-acquired pneumonia in immunocompromised patientsJournal of Infection, 2019
- Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcomeInfection, 2016